- Clinicaltrial.gov identifier:
- Locally Advanced or Metastatic Study, no CT no PAS (Post-Approval Studies), without drug
- Tumour subtype:
Aiming to understand the molecular aberrations in metastatic breast cancer
In order to exploit the potential of tumor molecular characterization, the Breast International Group (BIG) has set up AURORA – a large, multinational, collaborative metastatic BC (MBC) molecular screening program.
Piccart Martine, MD, PhD
Breast International Group (BIG) chair